Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy
AbstractCancer gene therapy expanded and reached its pinnacle in research in the last decade. Both viral and non-viral vectors have entered clinical trials, and significant successes have been achieved. However, a systemic administration of a vector, illustrating safe, efficient, and targeted gene delivery to solid tumors has proven to be a major challenge. In this review, we summarize the current progress and challenges in the targeted gene therapy of cancer. Moreover, we highlight the recent developments of bacteriophage-derived vectors and their contributions in targeting cancer with therapeutic genes following systemic administration. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Pranjol, M.Z.I.; Hajitou, A. Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy. Viruses 2015, 7, 268-284.
Pranjol MZI, Hajitou A. Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy. Viruses. 2015; 7(1):268-284.Chicago/Turabian Style
Pranjol, Md Z.I.; Hajitou, Amin. 2015. "Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy." Viruses 7, no. 1: 268-284.